Curcumin: a potential candidate for matrix metalloproteinase inhibitors

Author： Kumar Dileep   Kumar Manish   Saravanan Chinnadurai   Singh Sushil Kumar  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.10, 2012-10, pp. : 959-972

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Clinical Potential of Matrix Metalloproteinase Inhibitors in the Rheumatic Disorders

By Elliott S.   Cawston T.  

Drugs & Aging, Vol. 18, Iss. 2, 2001-02 ,pp. : 87-99

Adis International

Access to resources Recommend Favorite

Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis

By George S.J.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 5, 2000-05 ,pp. : 993-1007

Informa Healthcare

Access to resources Recommend Favorite

Matrix Metalloproteinase Knockout Studies and the Potential Use of Matrix Metalloproteinase Inhibitors in the Rheumatic Diseases

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 363-375

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1213-1216

Informa Healthcare

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors and cancer

By Lauer-Fields J.L.   Fields G.B.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. : 1873-1884

Informa Healthcare

Access to resources Recommend Favorite